USWM CT, LLC clinical trial pipeline

2 trials changed in the last 30 days: 1 stopped, 0 with notable changes, 1 with a minor change only.

1. Stopped

   ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in…ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ · MAGE-A4 Positive Ovarian Cancer (SURPASS-3)

   Trial terminated

   Also in this update: Final enrollment: 21 participants (planned 66); Primary completion date changed from estimate of Aug 12, 2026 to Sep 30, 2025

   USWM CT, LLC·Phase 2· NCT05601752· Registry history of NCT05601752 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.